ReviewJournal of immunotherapy and precision oncology2025

Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review.

Isabelle House et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.